https://www.selleckchem.com/JAK.html
Other studies are needed to confirm our results. Our data furtherly support peptide receptor radionuclide therapy as a safe and effective treatment of patients affected by pulmonary neuroendocrine neoplasms allowing disease control in about 71% of patients without showing significant toxicity. Other studies are needed to confirm our results. The goal of our retrospective single tertiary academic medical center investigation was to examine the added diagnostic value and clinical impact of Ga-DOTATATE PET/CT in the therapeutic management of patients w
Like
Comment
Share
